Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents

Intravitreal anti-vascular endothelial growth factor (VEGF) agents have obtained acceptance as the mainstay in the management strategy of subfoveal choroidal neovascular membranes (CNVM) due to varying etiologies. Few drawbacks include need for repeated intravitreal injections, with its adjunct risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagpal, Manish, Nagpal, Kamal, Mehta, Vikram
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684435/
https://www.ncbi.nlm.nih.gov/pubmed/19237791
http://dx.doi.org/10.4103/0301-4738.45507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684435/
https://www.ncbi.nlm.nih.gov/pubmed/19237791
http://dx.doi.org/10.4103/0301-4738.45507

Ejemplares similares